To keep its reputation as the “pharmacy of the world,” India needs a strong framework for regulating drugs, Union Health Minister JP Nadda stated on Wednesday.
This was said by the Union Health Minister on Wednesday during a high-level review meeting on the regulation of medications, cosmetics, and medical devices in the nation’s capital.
“We need to have a world-class regulatory framework matching our scale of operations and international expectations,” Nadda stated, “if India is to become the global leader in drug regulation to match our global reputation as the ‘Pharmacy of the World.”
This is in response to the US Food and Drug Administration and the European Medicines Agency, among others, having lately found contaminations in a number of medications manufactured in India.
Nadda emphasized India’s status as the world’s largest manufacturer and exporter of pharmaceuticals and encouraged the Central Drugs Standard Control Organization (CDSCO) to create a roadmap with deadlines for reaching international standards in the course of its authorized operations.
Upscaling “needs to be systems-based focussing on highest standards of uniformity, technical upgradation, and futuristic approach,” according to the minister.
He emphasized that the mechanism for pharmaceutical and drug exports should be set up for appropriate intervention to preserve the quality of the drugs being exported.
He also emphasized the significance of openness in CDSCO’s operations.
“Our focus needs to be on transparency of procedures at CDSCO and within the drugs and medical device industry in order to achieve global standards,” Nadda stated.
“We should concentrate on creating systems that guarantee the pharmaceutical industry can conduct business easily while adhering to regulatory standards. For this, he said, CDSCO must be an organization that is easy to use and has modern facilities that adhere to international norms.
